OMRON Healthcare Co., Ltd. has announced the U.S. launch of the VIVA 360+ Full-Body Smart Scale, a connected body composition monitor that measures up to 18 metrics and incorporates a new Athlete Mode. The product, which launches in the United States on October 13, 2026, with rollout to other markets expected in the coming months, reflects a growing consumer shift toward understanding health beyond simple body weight. The announcement, disseminated via NEWMEDIAWIRE, highlights how technology is responding to evolving health needs, including the rising use of GLP-1 medications and increased focus on fitness and weight management.
The importance of this launch lies in its response to a clear market gap: body weight alone often fails to capture meaningful changes in body composition. As more people pursue active lifestyles and manage conditions like obesity, tools that provide a more complete picture of health become essential. The VIVA 360+ uses four-point measurement with electrodes in both hands and feet, enabling segmental analysis of arms, trunk, and legs, including skeletal muscle and subcutaneous fat. New indicators such as body water percentage, bone mass, and fat-free mass offer a holistic view of how exercise, diet, and lifestyle choices affect the body. This is particularly relevant as GLP-1 medications drive interest in monitoring body fat, skeletal muscle, and body water.
A standout feature is Athlete Mode, designed for frequent or intensive exercisers such as runners and strength-training enthusiasts. Standard body composition algorithms can be less accurate for individuals with higher muscle mass relative to their BMI, so Athlete Mode uses athlete reference data to deliver tailored measurements. Integration with the OMRON Connect app further allows users to track trends over time through numerical values and graphs. Susan Rappin, Executive Director of Marketing at OMRON Healthcare, Inc., explained, “In developing VIVA 360+, we wanted to expand the information users can gain from a daily measurement while keeping the experience simple and accessible.” She added that Athlete Mode and new metrics were developed to help different types of users see progress not reflected in body weight alone.
Alice Koehler, Managing Director of OMRON Healthcare, Inc., emphasized the broader significance: “Body weight alone does not always tell the full story of a person's health journey. People are looking for meaningful insights that go beyond the number on a scale.” Building on more than 30 years of expertise in body composition monitoring, the VIVA 360+ aims to empower informed decisions for long-term health. The U.S. product webpage is available at OMRON VIVA 360+TM Smart Scale - OMRON Healthcare, Inc., and the full press release can be read at https://healthcare.omron.com/press-releases/omron-healthcare-launches-viva-360-plus-us. For more information, visit https://omronhealthcare.com/.
This launch matters because it addresses a critical gap in personal health monitoring. As obesity and lifestyle-related conditions remain major concerns, and as more consumers seek to track progress with GLP-1 medications, the ability to monitor body composition—not just weight—becomes increasingly valuable. By providing detailed metrics and specialized modes, OMRON Healthcare is positioning itself at the forefront of preventive care, helping users make data-driven decisions that support their long-term health.
